Fenster schließen  |  Fenster drucken

ChromaDex® to Present @Sixth Annual LD Micro Conference, on December 4, 2013 - Dec 2, 2013
http://app.quotemedia.com/quotetools/newsStoryPopup.go?story…

"IRVINE, Calif., Dec. 2, 2013 /PRNewswire/ -- ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it is scheduled to present at the 6th Annual LD Micro Conference on Wednesday, December 4, 2013, at 10:00 AM PST / 1:00 PM EST.

The three-day event will be held December 3 – 5 at the Luxe Sunset Bel Air Hotel in Los Angeles. More than 225 companies are expected to present. Frank Jaksch, Jr., CEO and co-founder of ChromaDex, will present on behalf of the Company. Investors interested in having a one-on-one meeting with Mr. Jaksch should contact Robert Prag at the The Del Mar Consulting Group, Inc. at the contact information provided below.


About ChromaDex®:

ChromaDex® is an innovative natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its unique business model that utilizes its wholly owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as "phytochemicals"), chemistry and analytical testing services, and product regulatory and safety consulting (as Spherix Consulting). The company provides seamless science-based solutions to the nutritional supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. The ChromaDex ingredient technologies unit includes products backed with extensive scientific research and intellectual property. Its ingredient portfolio includes pTeroPure® pterostilbene; ProC3G™, a natural black rice containing cyanidin-3-glucoside; PURENERGY™, a caffeine-pTeroPure co-crystal; and NIAGEN™, its recently launched branded nicotinamide riboside, a novel next-generation B vitamin. To learn more about ChromaDex, visit www.chromadex.com. "
 
aus der Diskussion: ChromaDex (smallcap) - A Philipp Frost (Billionair) Investment
Autor (Datum des Eintrages): Popeye82  (05.12.13 14:31:14)
Beitrag: 62 von 129 (ID:45986288)
Alle Angaben ohne Gewähr © wallstreetONLINE